MEYcell
The Problem
Consumers want sustainable meat, but they won't compromise on taste.
The alternative protein industry is growing rapidly as it seeks more sustainable food production methods. However, public adoption depends on delivering products that match conventional meat in taste, texture, and overall eating experience while remaining commercially scalable.
Rapidly Growing Market
Year-Round Production
Localized Manufacturing
Reduced Resource Consumption
The biggest obstacle isn't protein. It's fat.
Although today's plant-based meats can replicate protein structures, they still struggle to reproduce the unique sensory properties created by animal fat. Lipid composition determines juiciness, texture, and flavour release, which makes it one of the largest barriers to consumer adoption.
Consumers care about:
Taste
Texture
Aroma
Mouthfeel
Innovation alone isn't enough. Manufacturing must scale.
Commercial success requires infrastructure capable of manufacturing alternative proteins at competitive costs. Despite significant research investment and government support, large-scale production remains limited, slowing commercialization and delaying price parity with conventional meat.
Canada has high scale-up potential:
One breakthrough. A trillion-dollar opportunity.
Alternative proteins are entering a period of rapid commercialization, but widespread adoption still depends on delivering products consumers genuinely enjoy. By restoring the sensory experience of animal fat through a scalable fermentation platform, our technology addresses one of the industry's largest barriers while positioning itself within one of the fastest-growing sectors in food biotechnology.
Global Meat Industry
$0.0TUSD
Alternative Protein Market
$0-$0BUSD
Target Manufacturers
0-0Companies
Business Model
From fermentation to food manufacturers. Built for scale.
MEYcell is designed as a business-to-business ingredient platform, supplying engineered yeast lipids to alternative meat manufacturers. By leveraging existing fermentation infrastructure, recurring supply agreements, and scalable production, the business model prioritizes long-term manufacturing efficiency over direct consumer sales.
Revenue Streams
From the Lab to the Market
MEYcell's roadmap outlines the technical, regulatory, and manufacturing milestones required to transition from laboratory validation to commercial ingredient production through scalable fermentation and strategic industry partnerships.
Technology Readiness Level (TRL): 3-4
Different Technology. Different Position.
Alternative protein companies pursue similar goals through fundamentally different technologies. While cultivated meat, plant-based products, and precision fermentation each address sustainability challenges, MEYcell combines precision fermentation with a controlled lipid-release platform designed to improve sensory performance while maintaining scalable manufacturing.
Aleph Farms
Beyond Meat
MEYcell
Protecting the platform that produces, stores, and releases the lipid.
The IP strategy combines patent protection for the core platform and for future applications, with trade secret protection for the process. MEYcell plans to begin with a U.S. provisional patent and expand the portfolio as the technology and its applications develop. A formal freedom-to-operate analysis remains a planned step before commercialization.
Core Platform Patent
Platform Improvements
Formulation-Specific Protection
Application Specific Protection
International Protection in Commercially Relevant Markets